APELOA

Founded in 1989, Apeloa Pharmaceutical Co., Ltd. is a listed company on the main board of the Shenzhen Stock Exchange (SZSE: 000739) and the pharmaceutical industry development platform for Hengdian Group which is a well-known private enterprise in China. The company ranks among the top 40 pharmaceutical companies in China, the 25th in the "Top 100 Industrial Enterprises" (the second in Zhejiang), the second in the "API Export" (the first in Zhejiang), and the top 5 CDMO companies in Yaozhi.com. Apeloa was also elected to The 14th "Top 100 Most Valuable Listed Companies on the Main Board of China" and the second batch of Zhejiang "Eagle Action" Cultivation Enterprises. In recent years, it has successively won the honorary titles of Dongyang City's "Industrial Contribution Award" and "Top Ten Taxpayers" in Dongyang and Jinhua. After more than 30 years of development, Apeloa has established good pharmaceutical R&D and manufacturing capabilities, forming three main business sectors of..

Also known as: Apeloa Pharmaceutical, Apeloa Pharmaceutical Co., Ltd.

Primary location: Dongyang China